Nature’s Toolbox, Inc. (NTx) raised $47.5 million in the recent Series B funding round. The investment was led by RA Capital Management, and this funding will help the company in the advancement of its biomanufacturing platforms, NTxscribe and NTxpress.
NTx is a leading biotech startup that provides biomanufacturing for medicines. It’s proprietary biomanufacturing process is easily scalable and saves time and cost in comparison to traditional bioprocessing methods. The company has two host-independent manufacturing platforms that can be applied from small-scale pharma drug discovery to commercial large-scale production of biologics and therapeutics. This new investment will help the company carry forward its mission of delivering innovative biomanufacturing solutions.
The company’s CEO and Board of Director is Jamie Coffin, Ph.D., and it is headquartered in Rio Rancho, New Mexico, United States